Applied Genetic Technologies Corporation investor relations material

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. It focuses on developing adeno-associated virus (AAV)-based gene therapies to treat orphan diseases, including X-linked retinoschisis, achromatopsia, X-linked retinitis pigmentosa, and ocular albinism. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.